Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · IEX Real-Time Price · USD
0.541
-0.034 (-5.86%)
At close: Apr 25, 2024, 3:57 PM
0.550
+0.009 (1.61%)
After-hours: Apr 25, 2024, 8:00 PM EDT

Company Description

Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States.

The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.

It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.

The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023.

Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Catheter Precision, Inc.
Catheter Precision logo
Country United States
Founded 2002
IPO Date Aug 30, 2018
Industry Medical Devices
Sector Healthcare
Employees 14
CEO David A. Jenkins

Contact Details

Address:
1670 Highway 160 West, Suite 205
Fort Mill, South Carolina 29708
United States
Phone 973-691-2000
Website catheterprecision.com

Stock Details

Ticker Symbol VTAK
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001716621
ISIN Number US74933X3026
Employer ID 38-3661826
SIC Code 3841

Key Executives

Name Position
David A. Jenkins Chief Executive Officer and Executive Chairman
Margrit Thomassen CPA Interim Chief Financial Officer and Secretary
Missiaen Huck Chief Operating Officer

Latest SEC Filings

Date Type Title
Apr 3, 2024 8-K Current Report
Apr 2, 2024 8-K Current Report
Apr 1, 2024 10-K Annual Report
Feb 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Jan 25, 2024 8-K Current Report
Jan 16, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Jan 11, 2024 8-K Current Report
Jan 4, 2024 8-K Current Report
Dec 29, 2023 8-K Current Report
Dec 28, 2023 EFFECT Notice of Effectiveness